Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 16/20 | 0.85 |
| ▸ | F2 | P00734 | 19/20 | 0.84 |
| ▸ | KLKB1 | P03952 | 2/20 | 0.84 |
| ▸ | ELANE | P08246 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6593462 | 0.93 | F10 (0.85) | F10F2KLKB1ELANE | |
| SCHEMBL6593428 | 0.92 | F10 (1.00) | F10F2KLKB1ELANE | |
| SCHEMBL6590485 | 0.91 | F2 (0.81) | F10F2KLKB1ELANE | |
| SCHEMBL6589576 | 0.91 | F2 (1.00) | F10F2KLKB1ELANE | |
| SCHEMBL6590480 | 0.90 | F10 (0.81) | F10F2KLKB1ELANE | |
| SCHEMBL6590183 | 0.90 | F2 (0.86) | F10F2KLKB1ELANE | |
| SCHEMBL6592025 | 0.90 | F2 (1.00) | F10F2KLKB1ELANE | |
| SCHEMBL6591092 | 0.90 | F2 (0.84) | F10F2KLKB1ELANE | |
| SCHEMBL6597010 | 0.90 | F2 (0.84) | F10F2KLKB1ELANE | |
| SCHEMBL6590267 | 0.89 | F2 (1.00) | F10F2KLKB1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1040108-B1 | ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS | SCHERING AG (DE) | 2004-02-25 | — | — | EP | claimed |
| EP-1040108-B1 | ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS | SCHERING AG (DE) | 2004-02-25 | — | — | EP | disclosed |
| US-6498185-B1 | ENZYME FACTOR XA INHIBITORS | BERLEX LABORATORIES, INC. | 2002-12-24 | — | — | US | disclosed |
| US-6380221-B1 | FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY | BERLEX LABORATORIES, INC. | 2002-04-30 | — | — | US | disclosed |
| US-6140351-A | FOR TREATING THROMBOSIS | BERLEX LABORATORIES, INC. (US) | 2000-10-31 | — | — | US | disclosed |